| scholarly article | Q13442814 |
| retracted paper | Q45182324 |
| P356 | DOI | 10.1111/1346-8138.14079 |
| P698 | PubMed publication ID | 28980716 |
| P50 | author | Chau Yee Ng | Q86060175 |
| P2093 | author name string | Ya-Ching Chang | |
| Su-Hsun Liu | |||
| I-Shiang Tzeng | |||
| Yu-Huei Huang | |||
| P2860 | cites work | Insulin resistance and cigarette smoking | Q46042642 |
| Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism | Q46762078 | ||
| Effect of weight loss on some serum cytokines in human obesity: increase in IL-10 after weight loss | Q47280722 | ||
| Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort. | Q50562732 | ||
| Influence and variation of the body mass index in patients treated with etanercept for plaque-type psoriasis. | Q51753169 | ||
| Level of serum IL-12 and its correlation with endothelial dysfunction, insulin resistance, proinflammatory cytokines and lipid profile in newly diagnosed type 2 diabetes. | Q54116161 | ||
| Psoriasis | Q56115292 | ||
| Positive treatment effects of ustekinumab in psoriasis: Analysis of lesional and systemic parameters | Q61853643 | ||
| Anti-tumour necrosis factor-alpha treatment interferes with changes in lipid metabolism in a tumour cachexia model | Q72793736 | ||
| Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis | Q79610823 | ||
| Psoriasis and metabolic syndrome | Q82247584 | ||
| The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity | Q83630245 | ||
| Atherosclerosis in psoriatic disease: latest evidence and clinical implications | Q26783501 | ||
| Evidence that triglycerides are an independent coronary heart disease risk factor | Q34071541 | ||
| Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials | Q34189897 | ||
| Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. | Q34253312 | ||
| IL-17 regulates adipogenesis, glucose homeostasis, and obesity | Q34401701 | ||
| Accumulating evidence for the association and shared pathogenic mechanisms between psoriasis and cardiovascular-related comorbidities | Q34434622 | ||
| Effect of psoriasis activity on serum adiponectin and leptin levels. | Q35620533 | ||
| Triglyceride level is associated with wave reflections and arterial stiffness in apparently healthy middle-aged men. | Q35956140 | ||
| Perturbations of triglycerides but not of cholesterol metabolism are prevented by anti-tumour necrosis factor treatment in rats bearing an ascites hepatoma (Yoshida AH-130). | Q36081293 | ||
| Effect of inhibition of interleukin-12/23 by ustekinumab on the expression of leptin and leptin receptor in human THP-1 macrophages | Q36387222 | ||
| Psoriasis and psoriatic arthritis: clinical features and disease mechanisms | Q36590908 | ||
| Association of ustekinumab and briakinumab with major adverse cardiovascular events: An appraisal of meta-analyses and industry sponsored pooled analyses to date | Q36643600 | ||
| Pathogenesis and clinical features of psoriasis | Q36894005 | ||
| Psoriasis and metabolic disease: epidemiology and pathophysiology | Q37102789 | ||
| Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. | Q37354660 | ||
| Effects of tumor necrosis factor-alpha blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis | Q37394857 | ||
| Influence of ustekinumab on body weight of patients with psoriasis: an initial report | Q37634328 | ||
| Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies. | Q37742713 | ||
| The association between psoriasis and dyslipidaemia: a systematic review | Q38056160 | ||
| Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies | Q38077625 | ||
| Psoriasis and smoking: a systematic review and meta-analysis | Q38151781 | ||
| The Relationship of Obesity With the Severity of Psoriasis: A Systematic Review | Q38566345 | ||
| Relationship Between Serum IL-12 and p40 Subunit Concentrations and Lipid Parameters in Overweight and Obese Women | Q40874119 | ||
| Effects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritis | Q42498499 | ||
| Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials. | Q42613896 | ||
| The IL-23/IL-17 axis in inflammation | Q42825302 | ||
| The relationship between smoking and triglyceride-rich lipoproteins is modulated by genetic variation in the glycoprotein IIIa gene | Q43412831 | ||
| The risk of mortality in patients with psoriasis: results from a population-based study | Q43414443 | ||
| Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients | Q43813250 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 309-313 | |
| P577 | publication date | 2017-10-05 | |
| P1433 | published in | The Journal of Dermatology | Q18225322 |
| P1476 | title | Metabolic parameters in psoriatic patients treated with interleukin-12/23 blockade (ustekinumab). | |
| P478 | volume | 45 |
| Q92540268 | Change in body weight and body mass index in psoriasis patients receiving biologics: A systematic review and network meta-analysis |
| Q92104640 | Malondialdehyde, lipoprotein-a, lipoprotein ratios, comprehensive lipid tetrad index and atherogenic index as surrogate markers for cardiovascular disease in patients with psoriasis: a case-control study |
| Q46180528 | Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment |
| Q92043004 | Psoriatic Arthritis and Diabetes Mellitus: A Narrative Review |
| Q92277529 | Systemic Psoriasis Therapies and Comorbid Disease in Patients with Psoriasis: A Review of Potential Risks and Benefits |
Search more.